- Home
- FFC vs INMD Comparison
FFC vs INMD Comparison
Compare FFC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FFC | INMD |
|---|---|---|
| Founded | 1983 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 700.5M | 805.0M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | FFC | INMD |
|---|---|---|
| Price | $14.46 | $14.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $16.17 |
| AVG Volume (30 Days) | 224.8K | ★ 398.2K |
| Earning Date | 01-01-0001 | 11-11-2026 |
| Dividend Yield | ★ 6.79% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.30 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.38 | $12.72 |
| 52 Week High | $16.95 | $16.67 |
Technical Indicators
Market Signals| Indicator | FFC | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.37 | 38.40 |
| Support Level | $14.38 | $13.79 |
| Resistance Level | $16.34 | $14.18 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 17.31 | 28.75 |
Price Performance
Historical ComparisonAbout FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated
Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.